<DOC>
	<DOCNO>NCT00971295</DOCNO>
	<brief_summary>The primary objective investigate whether multiple-dose administration eslicarbazepine acetate affect pharmacokinetics metformin .</brief_summary>
	<brief_title>Effect Eslicarbazepine Acetate Pharmacokinetics Metformin Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Eslicarbazepine acetate</mesh_term>
	<criteria>Male female subject age 18 45 year , inclusive . Body mass index ( BMI ) 19 30 kg/m2 , inclusive . Healthy determine prestudy medical history , physical examination , vital sign , complete neurological examination 12lead ECG . Negative test HBsAg , antiHCVAb HIV1 HIV2 Ab screen Clinical laboratory test result clinically acceptable screen admission treatment period . Negative screen alcohol drug abuse screen admission treatment period . Nonsmokers smoke â‰¤ 10 cigarette equivalent per day . Able willing give write informed consent . ( If female ) Not childbearing potential reason surgery , childbearing potential , use one follow method contraception : double barrier intrauterine device . ( If female ) Negative urine pregnancy test screen admission treatment period . Clinically relevant history presence respiratory , gastrointestinal , renal , hepatic , haematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , endocrine , connective tissue diseases disorder . Clinically relevant surgical history . History relevant atopy drug hypersensitivity . History alcoholism drug abuse . Consumed 14 unit alcohol week . Significant infection know inflammatory process screen admission treatment period . Acute gastrointestinal symptom ( e.g. , nausea , vomit , diarrhoea , heartburn ) time screen admission treatment period . Used medicine within 2 week admission first period may affect safety study assessment , investigator 's opinion . Used investigational drug participate clinical trial within 6 month prior screen . Participated 2 clinical trial within 12 month prior screen . Donated receive blood blood product within 3 month prior screen . Vegetarians , vegan medical dietary restriction . Could communicate reliably investigator . Unlikely cooperate requirement study . Unwilling unable give write informed consent . ( If female ) Pregnant breastfeeding . ( If female ) Of childbearing potential use approve effective contraceptive method ( doublebarrier intrauterine device ) use oral contraceptive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>eslicarbazepine acetate</keyword>
	<keyword>zebinix</keyword>
	<keyword>metformin</keyword>
</DOC>